induct
monocytemacrophag
procoagul
activ
pca
implic
pathogenesi
murin
hepat
viru
strain
infect
diseas
previous
shown
induct
pca
correl
resistancesuscept
infect
differ
mous
strain
studi
balbcj
mice
infect
plaqueform
unit
develop
sever
liver
diseas
die
within
h
examin
liver
anim
show
mark
hepat
necrosi
deposit
fibrin
cellular
express
pca
direct
immunofluoresc
stain
area
necrosi
well
hepat
sinusoid
splenic
mononuclear
cell
recov
mice
express
high
concentr
pca
time
infect
infus
mice
hightit
monoclon
antibodi
neutral
pca
attenu
develop
hepat
necrosi
enhanc
surviv
dosedepend
manner
anim
receiv
g
anim
receiv
g
per
day
respect
surviv
made
full
recoveri
administr
antibodi
result
dosedepend
reduct
fibrin
deposit
pca
express
detect
direct
immunofluoresc
stain
function
assay
anim
treat
high
concentr
antibodi
titer
antibodi
pca
fell
ngml
activ
phase
diseas
consist
sequestr
due
bind
immunoglobulin
cell
express
pca
surviv
anim
rechalleng
mortal
consist
known
rate
metabol
immunoglobulin
suggest
protect
passiv
mechan
result
report
demonstr
neutral
antibodi
pca
protect
anim
fulmin
hepat
death
associ
infect
support
notion
pca
potent
inflammatori
mediat
play
pivot
role
pathogenesi
liver
injuri
result
infect
furthermor
use
recombin
inbr
strain
mice
show
genet
linkag
resistancesuscept
infect
induct
pca
control
two
recess
gene
infect
disturb
hepat
microcircul
associ
sinusoid
thrombosi
occur
coincid
rise
pca
intraven
infus
macrophag
induc
express
high
amount
pca
result
rapid
min
death
dissemin
intravascular
coagul
suscept
resist
mice
unpublish
observ
togeth
observ
suggest
coagul
necrosi
occur
result
induct
pca
may
crucial
featur
hepat
injuri
recent
produc
panel
mab
mhvinduc
macrophag
pca
antibodi
react
purifi
viral
protein
inhibit
viral
replic
one
mab
strongli
inhibit
pca
express
onestag
dot
assay
inhibit
convers
prothrombin
thrombin
antibodi
reactiv
murin
rabbit
human
tissu
factor
monoclon
bound
protein
distinct
murin
human
tissu
factor
kd
purpos
studi
determin
whether
treatment
specif
murin
antiprothrombinas
would
modifi
morbid
andor
mortal
associ
murin
hepat
viru
infect
viru
origin
growth
previous
describ
obtain
american
type
cultur
collect
kockvil
md
plaqu
purifi
monolay
dbt
cell
stock
viru
grown
titer
x
pfuml
cell
viru
harvest
one
cycl
freezethaw
clarifi
centrifug
g
h
viru
assay
monolay
cell
standard
plaqu
assay
previous
describ
induc
infect
mous
receiv
pfu
intraperiton
inject
mice
balbcj
mice
wk
age
obtain
charl
river
laboratori
st
constant
quebec
anim
hous
class
facil
univers
toronto
fed
diet
standard
chow
water
ad
libitum
mice
kill
day
infect
blood
obtain
axillari
bleed
splenic
mononuclear
cell
harvest
assay
pca
immunofluoresc
stain
onestag
clot
assay
liver
harvest
viral
titer
histopatholog
pca
immunofluoresc
stain
describ
mice
use
screen
elisa
exposur
mhv
found
neg
antipca
mat
prepar
mab
previous
describ
inject
hybridoma
cell
pristaneprim
mice
ascit
harvest
anim
treat
ascit
fluid
contain
g
mab
daili
preinfect
postinfect
pi
intraperiton
inject
standard
control
ascit
anim
infect
myeloma
cell
inject
six
separ
mice
ascit
fluid
whether
mice
reactiv
either
elisa
plaqu
reduct
assay
ensur
protect
effect
ascit
contain
mab
pca
specif
mab
pca
isol
hybridoma
supemat
affin
chromatographi
use
goat
antimous
igg
immobil
sepharos
pharmacia
montreal
quebec
immunoblot
analysi
column
eluat
confirm
igg
ig
present
subclass
analysi
elisa
previous
describ
confirm
subclass
present
g
purifi
mab
inject
mice
preinfect
pi
describ
histolog
histolog
assess
blind
observ
previous
describ
briefli
lir
cut
x
block
fix
immers
formalin
molar
phosphat
buffer
ph
fixat
tissu
dehydr
grade
alcohol
xylen
embed
paraffin
section
cut
stain
harri
hematoxylin
min
counterstain
eosin
section
wash
distil
water
dehydr
grade
alcohol
xylen
mount
parmount
group
five
anim
use
quantit
effect
mab
liver
histolog
digit
imag
analysi
system
hewlett
packard
co
ltd
mississauga
ontario
custom
softwar
use
constitut
modif
techniqu
describ
previous
area
necrosi
encircl
well
entir
section
yield
percentag
figur
repres
proport
diseas
liver
present
particular
section
anim
three
random
section
assay
fashion
mean
sd
calcuht
hbrin
deposit
assess
morrislendrum
hcromallori
stain
previous
describ
viral
titer
liver
snap
frozen
homogen
dmem
supplement
fc
mm
glutamin
homogen
previous
describ
viral
titer
liver
homogen
determin
monolay
cell
standard
plaqu
assay
spleen
harvest
asept
cell
teas
splenic
tissu
suspend
ml
dmem
previous
describ
smnc
isol
ficollhypaqu
gradient
densiti
pharmcia
centrifug
rain
cell
interfac
collect
viabil
assess
trypan
blue
exclus
cell
wash
three
time
resuspend
dmem
concentr
x
smncml
procoagut
activ
sampl
frozen
thaw
smnc
assay
capac
shorten
spontan
clot
time
human
citrat
plateletpoor
plasma
onestag
clot
assay
previous
describ
equal
volum
cellular
homogen
admix
citrat
normal
human
plateletpoor
plasma
mm
caclz
ad
start
reaction
time
second
appear
fibrin
gel
record
establish
arbitrari
unit
rabbit
brain
thromboplastin
standard
mg
dri
massml
dade
divis
american
hospit
suppli
miami
fl
assign
valu
mu
assay
use
rang
mu
result
linear
normal
human
plasma
substrat
data
convert
pca
per
splenic
macrophag
express
mean
standard
deviat
six
mice
done
triplic
media
buffer
without
activ
assay
inhibit
viral
replic
mab
purifi
hybridoma
cell
cultur
contain
ascit
assay
abil
inhibit
replic
standard
plaqu
reduct
assay
previous
describ
briefli
pfu
viru
admix
dilut
purifi
antibodi
ascit
media
neg
control
high
titer
antibodi
posit
control
min
mixtur
ad
monolay
cell
cultur
medium
overlay
agaros
incub
environ
addit
h
effect
antibodi
viral
replic
assess
reduct
viral
plaqu
immunofluoresc
block
liver
tissu
snap
frozen
liquid
nitrogen
cryostat
section
thick
fix
rain
aceton
air
dri
h
previous
describ
unoccupi
site
block
hors
serum
pb
ph
h
mab
conjug
fitc
sigma
chemic
co
st
loui
mo
accord
method
thi
feltkamp
fluorescein
antibodi
react
normal
liver
uninduc
normal
periton
macrophag
tissu
stain
fitcconjug
mab
h
room
temperatur
wash
three
time
mount
glycerol
pb
view
phaseepifluorec
microscop
equip
fluotar
object
e
leitz
inc
rockleigh
nj
elisa
antipca
antibodi
titr
antibodi
pca
determin
standard
elisa
previous
describ
enzym
immunoabsorb
assay
eia
plate
dynatech
mclean
va
coat
pcaposit
macrophag
membran
unstimuht
pcaneg
membran
x
macrophageml
overnight
plate
wash
three
time
pb
ph
conrain
tween
wash
buffer
unoccupi
site
block
igfre
hors
serum
flow
laboratori
mississauga
ontario
dissolv
wash
buffer
h
room
temperatur
dilut
sera
treat
anim
ad
plate
incub
h
wash
three
time
lwell
alkalin
phosphataseconjug
goat
antimous
ig
pb
contain
bsa
tween
ad
h
three
wash
pnitrophenyl
phosphat
buffer
ph
zyme
laboratori
san
francisco
ca
substrat
ad
plate
incub
h
read
nm
plate
reader
titertek
icnflow
mississauga
ontario
antibodi
level
express
gml
comparison
standard
curv
statisticalanalysi
statist
analysi
carri
use
analysi
varianc
wilcoxon
rank
sum
test
p
valu
less
consid
statist
signific
suwiv
mice
infect
pfu
n
succumb
infect
within
fig
consist
previou
data
report
group
well
other
contrast
surviv
anim
treat
ascit
contain
antibodi
pca
fig
anim
treat
ascit
contain
gd
surviv
treat
ascit
contain
gd
anim
treat
gd
surviv
anim
surviv
treat
g
monodon
antipca
purifi
hybridoma
superuat
confirm
benefici
effect
ascit
due
monoclon
antipca
mice
immun
ascit
anim
infect
die
within
data
shown
liver
histolog
mice
receiv
antibodi
develop
histolog
evid
sever
liver
diseas
h
pi
small
discret
loci
necrosi
spars
pmn
infiltr
could
seen
h
lesion
becam
pronounc
numer
fig
h
confluent
liver
necrosi
appar
fig
b
contrast
mice
infect
treat
antibodi
pca
show
mark
reduct
liver
diseas
group
small
loci
inflammatori
cell
necrosi
fig
morphometr
imag
analysi
show
proport
liver
necrot
significantli
differ
antipcatr
untreat
group
h
fig
histolog
liver
survivor
postinfect
appear
normal
fibrin
deposit
seen
hepat
sinusoid
well
area
necrosi
untreat
mice
fig
anim
treat
antipca
mark
reduct
fibrin
note
fibrin
seen
liver
infect
mice
treat
mab
treatment
antipca
alon
result
detect
histolog
evid
liver
diseas
nonirlf
anim
viral
titer
h
pi
larg
amount
infecti
viru
recov
liver
homogen
untreat
anim
persist
death
anim
fig
anim
treat
antibodi
pca
signific
differ
viral
titer
observ
untreat
mice
day
viral
titer
remain
high
day
howev
viral
titer
decreas
day
viru
could
detect
day
anim
treat
highest
dose
antibodi
pca
gd
viral
titer
markedli
reduc
p
approach
seen
resist
aj
mice
use
method
reed
meunch
recov
infect
antibodytr
anim
pathogen
stock
viru
recov
infect
untreat
mice
data
shown
pca
untreat
anim
sharp
increas
splenic
macrophag
pca
note
h
pi
fig
maxim
pca
seen
h
pca
remain
elev
anim
death
day
anim
treat
low
concentr
antibodi
pca
express
high
amount
pca
earli
time
point
day
pca
level
fell
basal
level
pca
detect
smnc
day
contrast
express
pca
could
detect
anim
treat
antibodi
pca
cours
infect
fig
immunofluoresc
direct
immunofluoresc
stain
pca
could
detect
h
liver
infect
untreat
mice
pca
seen
area
inflamm
necrosi
also
hepat
sinusoid
local
primarili
endotheli
cell
kupffer
cell
express
hepatocyt
fig
liver
anim
treat
antibodi
pca
significantli
less
pca
express
although
small
amount
pca
could
seen
macrophag
endotheli
cell
hepat
sinusoid
anim
treat
highdos
antibodi
pca
tgd
even
late
day
fig
antibodi
pca
sera
collect
anim
time
point
analyz
elisa
presenc
antibodi
pca
previous
describ
antibodi
pca
could
detect
sera
normal
control
anim
anim
infect
receiv
antibodi
pca
data
shown
sera
anim
treat
ascit
contain
antibodi
pca
contain
larg
amount
antipca
infect
infect
concentr
circul
antibodi
fell
remain
ngml
anim
treat
anim
treat
antibodi
day
antibodi
undetect
ngml
fig
antibodi
pca
either
ascit
purifi
supernat
neutral
standard
plaqu
reduct
assay
previous
describ
determin
whether
treat
anim
surviv
acut
infect
develop
longterm
resist
infect
mice
previous
infect
treat
antibodi
n
infect
pfu
last
exposur
viru
pca
antibodi
titer
group
present
antibodi
therapi
consist
known
rate
disappear
igg
mhvrechalleng
mice
experienc
mortal
rate
suggest
protect
passiv
immun
antibodi
acquir
activ
immun
process
fig
addit
antibodi
detect
mice
either
rechalleng
viru
infect
produc
fulmin
hepat
failur
death
balbcj
mice
avail
mab
pca
neutral
acceler
coagul
vitro
provid
us
opportun
directli
examin
role
pca
vivo
murin
hepat
viru
strain
infect
balbcj
mice
infect
pfu
develop
sever
liver
diseas
die
within
h
administr
mab
pca
attenu
hepat
necrosi
fibrin
deposit
enhanc
surviv
dosedepend
manner
anim
receiv
anim
receiv
respect
surviv
made
full
recoveri
furthermor
protect
effect
seen
mice
treat
purifi
hybridoma
cultur
supernat
increas
surviv
treat
anim
specif
antipca
sinc
ascit
mice
inject
cell
alon
contain
antibodi
pca
fail
protect
mice
infect
although
antibodytr
anim
demonstr
clinic
evid
viral
hepat
earli
cours
infect
behavior
appear
normal
liver
section
show
littl
appar
diseas
examin
liver
antibodytr
anim
show
mark
reduct
hepat
necrosi
inflammatori
cell
neutrophil
mononuclear
cell
promin
featur
infect
pca
express
featur
infect
mous
strain
untreat
mice
pca
detect
immunofluoresc
stain
area
necrosi
well
hepat
sinusoid
macrophag
endotheli
cell
express
detect
pca
hepatocyt
like
hepat
necrosi
secondari
ischem
chang
result
induct
pca
lead
deposit
fibrin
administr
mab
result
dosedepend
reduct
deposit
fibrin
express
pca
detect
immunofluoresc
stain
liver
direct
function
assay
smnc
previous
shown
infect
periton
macrophag
vitro
result
product
pca
tnf
leukotrien
thu
express
pca
endotheli
ceil
might
either
due
direct
induct
due
induct
andor
tnf
previous
shown
induc
pca
endotheli
cell
vitro
treatment
mice
mab
pca
increas
surviv
reduc
hepat
necrosi
also
result
one
possibl
explan
decreas
viral
replic
observ
mice
treat
antibodi
antibodi
react
mhv
receptor
recent
describ
holm
cowork
regard
explan
unlik
sinc
show
neutraliza
tion
viral
infect
plaqu
reduct
assay
wherea
antibodi
mhv
receptor
inhibit
infect
furthermor
mhv
receptor
molecular
mass
kd
consider
differ
pca
molecul
kd
second
possibl
explan
effect
antipca
antibodi
growth
mice
relat
normal
cleavag
mhv
protein
shown
cleavag
proteas
necessari
activ
membranefus
properti
protein
fusion
properti
facilit
spread
viru
uninfect
cell
cellcel
fusion
also
increas
specif
infect
mhv
compar
viru
cleav
possibl
infect
macrophag
pca
serin
proteas
mediat
least
part
proteolyt
cleavag
therebi
activ
fusion
properti
molecul
consist
idea
observ
infect
aj
macrophag
produc
pca
respons
mhv
infect
result
appear
syncyti
giant
cell
unpublish
observ
thu
antibodi
pca
could
inhibit
spread
viru
uninfect
cell
decreas
activ
fusion
properti
although
mechan
antipca
treatment
protect
suscept
anim
clear
use
antibodi
pca
neutral
pca
therebi
prevent
activ
coagul
system
inhibit
fibrin
format
antibodi
could
also
result
complementmedi
destruct
cell
express
membranebound
pca
promot
macrophag
activ
restrict
viral
growth
anim
treat
g
antibodi
infect
pi
concentr
antibodi
pca
sera
fell
infect
ngml
activ
phase
diseas
day
consist
sequestr
perhap
due
bind
ig
cell
express
pca
furthermor
mice
level
pca
smnc
remain
basal
level
anim
treat
lower
amount
antibodi
gd
pca
hepat
necrosi
surviv
partial
attenu
antibodi
detect
ngml
day
pi
togeth
data
strongli
support
notion
antipca
antibodi
neutral
pca
vivo
infect
may
basi
protect
effect
previou
report
demonstr
dimethyl
prostaglandin
inhibit
procoagul
activ
prevent
fulmin
viral
hepat
yet
anim
still
succumb
infect
pgetreat
mice
viral
replic
proceed
rate
similar
untreat
anim
recent
demonstr
although
inhibit
function
pca
antigen
express
pca
alter
determin
western
immunoblot
propos
pca
may
exert
effect
activ
coagul
system
microvascular
macrovascular
thrombosi
present
result
concert
inhibit
studi
pca
suggest
pca
site
action
well
protect
effect
mab
pca
occur
even
though
balbcj
mice
fail
mount
antivir
humor
respons
observ
consist
recent
report
korner
et
al
support
notion
murin
antivir
antibodi
respons
may
requir
protect
acut
viral
infect
cytokin
play
potent
role
cours
inflammatori
injuri
vivo
interfer
action
alter
cours
certain
inflammatori
diseas
treatment
rat
recombin
antibodi
tnf
shown
protect
anim
hypotens
hypothermia
mortal
gramneg
sepsi
treatment
rabbit
antagonist
reduc
mortal
associ
endotoxin
shock
studi
support
notion
induct
pca
infect
mice
integr
potenti
central
step
diseas
previou
report
taylor
et
al
demonstr
lethal
escherichia
coli
septic
shock
prevent
block
tissu
factor
distinct
procoagul
mab
demonstr
import
cellular
coagul
pathophysiolog
infecti
diseas
conclud
pca
potent
inflammatori
mediat
play
pivot
role
hepat
injuri
result
infect
